Tumor Ablation Market By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Other Technologies), By Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, Other Application) - Growth, Future Prospects And Competitive Analysis 2015 – 2025

Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as rising prevalence of different forms of cancer, technological  advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally.

The report titled “Tumor Ablation Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall tumor ablation market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on technology radiofrequency ablation, microwave ablation, cryoablation and other technologies, treatment surgical ablation, laparoscopic ablation and percutaneous ablation, application liver cancer, lung cancer, kidney cancer, bone metastasis and other applications and different geographical regions. Geographically, the global tumor ablation market is studied for the following regional markets:  

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa
•  

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global tumor ablation market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global tumor ablation market. 

This report concludes with company profiles section that highlights major information about the key players engaged in global tumor ablation market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.   

Based on application, the global tumor ablation market is segmented as follows:  

• Liver cancer
• Lung cancer
• Kidney cancer
• Bone metastasis
• Other applications
•  

Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung. Special probes are used to burn or freeze tumor without the usual surgery; these treatments are also sometimes performed in patients waiting for liver transplant. Factors such as rising prevalence of different forms of cancer, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that, in the base year 2016, liver cancer is largest revenue generating segment because of increase in prevalence of liver cancer and tumor ablation is globally accepted procedure in treatment of solid tumors in liver for patient where surgical procedure is not possible or preferred. Tumor ablation are also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.

For the purpose of this study, the global tumor ablation market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In the base year 2016, North America dominated the tumor ablation market in terms of revenue and it is anticipated that it will show significant growth during forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances and upsurge funding by the government are the prime contributors to the dominance of North America. 

It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic condition, improved treatment access, improvement in awareness among general patient population, rising medical expenditures in emerging economies such as India, China and Japan, growing market penetration of major players in this region would drive the market growth in Asia Pacific during forecast period 2017-2025.